{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-017882","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.974648+00:00","generated_at":"2026-05-26T23:29:01.442596+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Revelation Biosciences posts updated corporate presentation; no new specific data in filing","bullets":["Corporate presentation dated February 10, 2025 made available on company website; content not summarized in the 8-K.","Investors must access the company's investor relations page to view the presentation; no material updates disclosed in the filing.","No changes to financial outlook, pipeline, or guidance were announced in this Form 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-017882","json":"https://secwatch.observer/filing/0000950170-25-017882.json","markdown":"https://secwatch.observer/filing/0000950170-25-017882.md","text":"https://secwatch.observer/filing/0000950170-25-017882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025017882/0000950170-25-017882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025017882/revb-20250210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:29:01.442596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}